$EMBC News
Last published 2mo ago
- 2mo agoEMBCembecta to Participate in Investor EventsGlobeNewswirePARSIPPANY, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical
- 3mo agoEMBCEmbecta Third Quarter of Fiscal Year 2026 Earnings Conference Call - EMBECTA CORPEarnings Call TranscriptsWelcome, ladies and gentlemen, to Embecta Corporation's first third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. Please note that this conference call is being recorded
- 3mo agoEMBCEmbecta Corp. Reports Third Quarter Fiscal 2026 Financial ResultsGlobeNewswirePARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies
- 3mo agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of
- 3mo agoEMBCSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBCPR NewswireNovember 25, 2025. January 14, 2026. February 5, 2026. May 5, 2026. Between these dates, Embecta Corp. (NASDAQ: EMBC) shareholders watched management ...
- 3mo agoEMBCembecta to Report Fiscal Third Quarter Financial ResultsGlobeNewswirePARSIPPANY, N.J., July 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies
- 3mo agoEMBCThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBCPR NewswireThe Gross Law Firm issues the following notice to shareholders of Embecta Corp. (NASDAQ: EMBC). Shareholders who purchased shares of EMBC during the...
- 4mo agoEMBCERASHUBGGTMAttention Long-Term Shareholders of Embecta Corp. (NSADAQ: EMBC); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, July 10, 2026 (GLOBE NEWSWIRE) -- EMBECTA CORP. (NASDAQ:EMBC): Grabar Law Office is investigating whether certain officers and directors of Embecta Corp. (NASDAQ:EMBC) ("Embecta" or the
- 4mo agoEMBCERASNAVNPSIXGrabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Embecta Corp. (NASDAQ: EMBC); Navan, Inc. (NASDAQ: NAVN); and Power Solutions International, Inc. (NASDAQ: PSIX)GlobeNewswirePHILADELPHIA, June 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (NASDAQ:EMBC): Grabar Law Office is investigating whether certain officers and directors of Embecta Corp. (NASDAQ:EMBC) ("Embecta" or the
- 4mo agoEMBCembecta appoints Nimish Muzumdar as SVP and President, North AmericaGlobeNewswirePARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 5mo agoEMBCembecta to Participate in Investor EventsGlobeNewswirePARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies
- 6mo agoEMBCembecta Completes Acquisition of Owen Mumford Holdings LimitedGlobeNewswirePARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to
- 6mo agoEMBC2026 GLOBAL HEALTHCARE CONFERENCE - EMBECTA CORPEarnings Call TranscriptsHi, everybody. I'm Gratia Mahoney, a MedTech analyst here at Bank of America, and today I'm joined by Dev Kurtykar, CEO and President of Invecta. Thanks for joining us today, Dev. It's a pleasure to be here. Thank you fo
- 6mo agoEMBCembecta to Participate at the 2026 BofA Securities Global Health Care ConferenceGlobeNewswirePARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ:EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday,
- 6mo agoEMBCEmbecta Second Quarter of Fiscal Year 2026 Earnings Conference Call - EMBECTA CORPEarnings Call TranscriptsWelcome, ladies and gentlemen, to Invector Corp's Fiscal Second Quarter 2026 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being
- 6mo agoEMBCEmbecta Corp. Reports Second Quarter Fiscal 2026 Financial ResultsGlobeNewswirePARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 6mo agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the
- 6mo agoEMBCembecta to Report Fiscal Second Quarter Financial ResultsGlobeNewswirePARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 9mo agoEMBCembecta names new Chairman of the Board and Lead Independent DirectorGlobeNewswirePARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 9mo agoEMBCEMBECTA FIRST QUARTER OF FISCAL YEAR 2026 EARNINGS CONFERENCE CALL - EMBECTA CORPEarnings Call TranscriptsWelcome, ladies and gentlemen, to the Embecta Corp's Fiscal First Quarter 2026 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is bei
- 9mo agoEMBCEmbecta Corp. Reports First Quarter Fiscal 2026 Financial ResultsGlobeNewswirePARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 9mo agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the
- 9mo agoEMBCembecta to Report Fiscal First Quarter Financial ResultsGlobeNewswirePARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 10mo agoEMBCembecta to Participate at the J.P. Morgan 2026 Healthcare ConferenceGlobeNewswirePARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ:EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14,
- 11mo agoEMBCEmbecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial GuidanceGlobeNewswirePARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (NASDAQ:EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month
- 11mo agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the
- 11mo agoEMBCembecta announces changes to Board of DirectorsGlobeNewswirePARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 12mo agoEMBCembecta Announces Major New Commitment to Direct Relief on World Diabetes DayGlobeNewswirePARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. ("embecta") (NASDAQ:EMBC), the largest manufacturer of insulin injection devices in the world, today announced a significant
- 1y agoEMBCembecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 1y agoEMBCembecta to Participate in Investor EventsGlobeNewswirePARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies
- 1y agoEMBCEmbecta Corp. (EMBC) Q3 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoEMBCEmbecta Corp. Reports Third Quarter Fiscal 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (NASDAQ:EMBC), a global diabetes care company, today reported financial results for the three and nine month
- 1y agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the
- 1y agoEMBCembecta to Report Fiscal Third Quarter 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
- 1y agoEMBCembecta to Participate in Investor EventsGlobeNewswirePARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies
- 1y agoEMBCembecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor DayGlobeNewswirePARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its
- 1y agoEMBCEmbecta Corp. Reports Second Quarter Fiscal 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (NASDAQ:EMBC), a global diabetes care company, today reported financial results for the three and six month periods
- 1y agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the
- 1y agoEMBCEmbecta to host Analyst and Investor Day on May 22, 2025GlobeNewswirePARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on
- 1y agoEMBCembecta to Report Fiscal Second Quarter 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal
- 1y agoEMBCMayo Clinic Proceedings Publishes New Global Insulin Injection RecommendationsGlobeNewswirePARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark
- 1y agoBAXBMRNEMBCHSIC+2PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee ChairBusiness WireFormer Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a
- 1y agoBAXBMRNEMBCHSIC+1Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee ChairBusiness WireFormer Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company
- 1y agoEMBCembecta to Participate at the J.P. Morgan Global Leveraged Finance ConferenceGlobeNewswirePARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ:EMBC) today announced that Jake Elguicze, embecta's Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance
- 1y agoEMBCEmbecta Corp. Reports First Quarter Fiscal 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (NASDAQ:EMBC), a global diabetes care company, today reported financial results for the three month period ended
- 1y agoEMBCembecta Announces Quarterly Cash DividendGlobeNewswirePARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (NASDAQ:EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the
- 1y agoEMBCembecta to Report Fiscal First Quarter 2025 Financial ResultsGlobeNewswirePARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal
- 1y agoEMBCembecta to Participate at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswirePARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ:EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 15,
- 1y agoEMBCEmbecta Corp. (EMBC) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoEMBCEmbecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce CostsGlobeNewswirePARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (NASDAQ:EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month